Vanguard Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.3K Buy
21,974
+2,113
+11% +$5.46K ﹤0.01% 3896
2026
Q2
$52.2K Hold
19,861
– – ﹤0.01% 3933
2026
Q1
$38.3K Buy
+19,861
New +$41.9K ﹤0.01% 3944

Other funds holding KPRX

Vanguard Capital Management's KPRX Position: Q3 2026 in Review

Vanguard Capital Management increased its Kiora Pharmaceuticals (KPRX) stake by 11% in Q3 2026, buying an estimated $5.46K and bringing the position to 21,974 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3896.

Vanguard Capital Management first reported a position in KPRX in Q1 2026 and has held it in 3 quarters since. 12 funds tracked by Wall St. Rank hold KPRX as of Q3 2026.

  • Vanguard Capital Management held 21,974 shares of Kiora Pharmaceuticals worth $56.3K as of Q3 2026.
  • Vanguard Capital Management bought 2,113 Kiora Pharmaceuticals shares in Q3 2026, an estimated $5.46K.
  • Kiora Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3896 holding.
  • Vanguard Capital Management first reported a position in Kiora Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 12 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.